SurgePays, Inc. (SURG)
(Delayed Data from NSDQ)
$1.94 USD
+0.05 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.93 -0.01 (-0.52%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
SurgePays, Inc. [SURG]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Company: SurgePays, Inc.
Industry: Internet - Software
Lowering Price Target To $2 From $3, As We Lower Estimates Following 2Q:24 Results
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
We Take A More Conservative Stance Ahead Of 2Q:24 Results
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Increased Optimism As Signs Emerge That The Affordable Connectivity Program Could Be Funded
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Expect Solid 1Q:24 Results With 2Q:24 Being A Reset Quarter As ACP Funding Remains Unclear
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Initiate Coverage With $4 Price Target, Moderate Risk Rating
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Initiate Coverage With $4 Price Target, Moderate Risk Rating
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Optimized Entry and Exit Levels for SURG 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Medical - Instruments
Company: SurgePays, Inc.
Industry: Medical - Instruments
SURG Q1/12 results solid; Lowering to Neutral on reaching price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: SurgePays, Inc.
Industry: Medical - Instruments
Company: SurgePays, Inc.
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for SURG
Provider: VALUENGINE, INC
Company: SurgePays, Inc.
Industry: Medical - Instruments
Q2/11 positive, market downturn presents short-term buying opportunity
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: SurgePays, Inc.
Industry: Medical - Instruments
A FOUR STAR PATENTVEST IP VALUE COMPANY - 2011 "BEST AND BRIGHTEST" PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
Company: SurgePays, Inc.
Industry: Medical - Instruments
we are initiating coverage on SURG with a BUY rating and 12-18 month price target of $6.25 per share
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
|